Larry R Thomas

US Patent:

6338847, Jan 15, 2002

Filed:

Feb 28, 1994

Appl. No.:

08/203837

Inventors:

Larry K. Thomas - Fullerton CA

Assignee:

Allergan - Waco TX

International Classification:

A61K 3854

US Classification:

424 942, 424 944, 424 946, 424 9461, 424 9462, 424 9463, 424 9464, 424 9465, 424 9466, 424 9467, 422 30, 252 95, 252106, 25217412, 25217413

Abstract:

Compositions and methods to disinfect contact lenses are disclosed. In one embodiment, the present composition comprises a cellulose decomposing enzyme component, e. g. , lysozyme, and a hydrogen peroxide destroying component. The composition is structured so that the cellulose decomposing enzyme component is released in a liquid medium containing hydrogen peroxide before the hydrogen peroxide destroying component is released in the liquid medium. Such cellulose decomposing enzyme component is preferably effective to render hydrogen peroxide-resistant microorganisms, e. g. , acanthamoeba cysts, which may contaminate the lens more susceptible to being killed by hydrogen peroxide.

US Patent:

6767899, Jul 27, 2004

Filed:

Aug 29, 2000

Appl. No.:

09/650055

Inventors:

Robert A. Kay - LaMirada CA
Larry K. Thomas - Irvine CA
Beuford A. Bogue - Carson CA

Assignee:

Leiner Health Services Corp. - Carson CA

International Classification:

A61K 3170

US Classification:

514 62, 424461, 536 552

Abstract:

Compositions and methods of treatment for conditions in humans and animals which have an inflammatory component, are disclosed. The composition comprises a glucosamine component dispersed in a controlled-release matrix system capable of releasing the glucosamine over a designated time period. In another aspect, the invention provides compositions and methods for the treatment of arthritis in humans and animals without adversely effecting glucose regulation.

US Patent:

6887492, May 3, 2005

Filed:

Dec 14, 2001

Appl. No.:

10/017478

Inventors:

Robert A. Kay - LaMirada CA, US
Larry K. Thomas - Irvine CA, US

Assignee:

Leiner Health Services Corp. - Carson CA

International Classification:

A61K009/28
A61K009/20
A61K009/22
A61K009/48
A61K009/24

US Classification:

424474, 424464, 424468, 424463, 424451, 424457, 424472

Abstract:

The present invention is an orally administered pharmaceutical composition that provides for the controlled release of magnesium. The composition has an interactive agent component and a magnesium component which has an enteric coating that controls the release of the magnesium until the composition is in the small intestine or colon. The other component is released in the stomach and is substantially absorbed prior to the release of the magnesium component. Normally, the interactive agent component decreases the absorption of magnesium when the two components are released simultaneously in the gastrointestinal tract.

US Patent:

7338942, Mar 4, 2008

Filed:

Jun 9, 2004

Appl. No.:

10/865404

Inventors:

Robert A. Kay - LaMirada CA, US
Larry K. Thomas - Irvine CA, US
Beuford A. Bogue - Carson CA, US

Assignee:

Leiner Health Services, Corp. - Carson CA

International Classification:

A61K 31/715
A61K 31/70

US Classification:

514 54, 514 62, 562 552, 424461

Abstract:

Compositions and methods for maintaining healthy mobile joints and cartilage in humans and animals are disclosed. The composition comprises glucosamine and chondroitin dispersed in a controlled-release matrix system capable of releasing the glucosamine and chondroitin over a designated time period. In another aspect, the invention provides compositions and methods for maintaining health mobile joints and cartilage in humans and animals without adversely affecting glucose regulation.

US Patent:

D633821, Mar 8, 2011

Filed:

Mar 19, 2010

Appl. No.:

29/349246

Inventors:

Jason Hill - Long Beach CA, US
Tom Reichenbach - Carlsbad CA, US
Kurt Danielson - Carlsbad CA, US
Larry Thomas - Carlsbad CA, US
Miles Wheeler - Seattle WA, US
Marques McCammon - San Marcos CA, US
Paul Wilbur - West Bloomfield MI, US
Nathan Armstrong - Calgary, CA
Dean Bartolomucci - Columbus MI, US

Assignee:

Aptera Motors, Inc. - Vista CA

International Classification:

1208

US Classification:

D12 85

US Patent:

D635487, Apr 5, 2011

Filed:

Mar 19, 2010

Appl. No.:

29/349245

Inventors:

Jason Hill - Long Beach CA, US
Tom Reichenbach - Carlsbad CA, US
Kurt Danielson - Carlsbad CA, US
Larry Thomas - Carlsbad CA, US
Miles Wheeler - Seattle WA, US
Marques McCammon - San Marcos CA, US
Paul Wilbur - West Bloomfield MI, US
Nathan Armstrong - Calgary, CA
Dean Bartolomucci - Columbus MI, US

Assignee:

Aptera Motors, Inc. - Vista CA

International Classification:

1208

US Classification:

D12 85

US Patent:

53125886, May 17, 1994

Filed:

Nov 6, 1991

Appl. No.:

7/788340

Inventors:

Peter Gyulai - Santa Ana CA
Larry K. Thomas - Fullerton CA
Hermann Osterwald - Bovenden-Eddigehausen, DE

Assignee:

Allergan, Inc. - Irvine CA

International Classification:

A61L 900

US Classification:

422 30

Abstract:

A composition and methods useful for making such compositions and for using such compositions to destroy hydrogen peroxide in a liquid aqueous medium, such as that used to disinfect contact lenses, are disclosed. The composition comprises a coated core containing at least one hydrogen peroxide destroying component effective when released into a liquid aqueous medium to destroy or cause the destruction of hydrogen peroxide present in the liquid aqueous medium, and a barrier coating acting to substantially prevent the release of the hydrogen peroxide destroying component for a period of time after the composition is initially contacted with a hydrogen peroxide-containing liquid aqueous medium. The barrier coating is substantially water soluble, preferably includes polyvinylpyrrolidone and is applied as a substantially dry, solid material.

US Patent:

57469725, May 5, 1998

Filed:

Nov 1, 1996

Appl. No.:

8/742356

Inventors:

John Y. Park - Santa Ana CA
Larry K. Thomas - Irvine CA
Lin Peng - Sunnyvale CA
Daniel P. Cafaro - Walnut Creek CA

Assignee:

Allergan - Waco TX

International Classification:

A61L 218
C12N 908

US Classification:

422 30

Abstract:

Compositions and methods for disinfecting and cleaning contact lenses include a liquid medium containing hydrogen peroxide and a defined ethylene oxide/propylene oxide block copolymer. An advantageously reduced amount of foaming occurs when the hydrogen peroxide is destroyed, particularly by the action of catalase.